Editorial response: Discordance between virological, immunologic, and clinical outcomes of therapy with protease inhibitors among human immunodeficiency virus-infected patients

被引：6
|
作者：
Goetz, MB
机构：
[1] Vet Adm Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
来源：
CLINICAL INFECTIOUS DISEASES | 1999年 / 29卷 / 06期
关键词：
D O I：
10.1086/313563
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1431 / 1434
页数：4
相关论文
共 50 条
  • [1] Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients
    Le Moing, V
    Chêne, G
    Leport, C
    Lewden, C
    Duran, S
    Garré, M
    Masquelier, B
    Dupon, M
    Raffi, F
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (02) : 239 - 247
  • [2] Outcomes in human immunodeficiency virus-infected pregnant women treated with protease inhibitors
    Einstein, FH
    Wright, R
    Trentacoste, S
    Chazotte, C
    Merkatz, IR
    Bernstein, PS
    OBSTETRICS AND GYNECOLOGY, 2004, 103 (04): : 24S - 24S
  • [3] Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis
    Narita, M
    Stambaugh, JJ
    Hollender, ES
    Jones, D
    Pitchenik, AE
    Ashkin, D
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (05) : 779 - 783
  • [4] Impact of protease inhibitors on the outcome of human immunodeficiency virus-infected patients with chronic diarrhea
    Bini, EJ
    Cohen, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (12): : 3553 - 3559
  • [5] Early experience with protease inhibitors in human immunodeficiency virus-infected children
    Sáez-Llorens, X
    Ramilo, O
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (08) : 728 - 738
  • [6] Virologic and immunologic response to nucleoside reverse-transcriptase inhibitor therapy among human immunodeficiency virus-infected infants and children
    Palumbo, PE
    Raskino, C
    Fiscus, S
    Pahwa, S
    Schutzbank, T
    Spector, SA
    Baker, CJ
    Englund, JA
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03): : 576 - 583
  • [7] Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children
    Borkowsky, W
    Stanley, K
    Douglas, SD
    Lee, S
    Wiznia, A
    Pelton, S
    Yogev, R
    McIntosh, K
    Nachman, S
    JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01): : 96 - 103
  • [8] Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppression
    Dieleman, JP
    Sturkenboom, MCJM
    Wit, FW
    Jambroes, M
    Mulder, JW
    ten Veen, JH
    Juttmann, J
    Stricker, BHC
    Lange, JMA
    van der Ende, ME
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (09): : 1261 - 1268
  • [9] Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy
    Wellons, MF
    Ottinger, JS
    Weinhold, KJ
    Gryszowka, V
    Sanders, LL
    Edwards, LJ
    Gooding, ME
    Thomasch, JR
    Bartlett, JA
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (10): : 1522 - 1525
  • [10] Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
    Singh, N
    Berman, SM
    Swindells, S
    Justis, JC
    Mohr, JA
    Squier, C
    Wagener, MM
    CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) : 824 - 830
12345